Hoxa5 undergoes dynamic DNA methylation and transcriptional repression in the adipose tissue of mice exposed to high-fat diet

International Journal of Obesity

Volumn 40, Issue 6, 2016, Pages 929-937

  Parrillo, L ^a,b   Costa, V ^c   Raciti, G A ^a,b   Longo, M ^a,b   Spinelli, R ^a,b   Esposito, R ^c   Nigro, C ^a,b   Vastolo, V ^a,b   Desiderio, A ^a,b   Zatterale, F ^a,b   Ciccodicola, A ^c,d   Formisano, P ^a,b   Miele, C ^a,b   Beguinot, F ^a,b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

^d UNIVERSITY OF NAPLES PARTHENOPE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3A; MESSENGER RNA; METHYL CPG BINDING PROTEIN; HOMEODOMAIN PROTEIN; HOXA5 PROTEIN, MOUSE; PHOSPHOPROTEIN;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ARTICLE; DATA ANALYSIS; DNA METHYLATION; EPIDIDYMIS FAT; EPIGENETICS; GENE; GENE ONTOLOGY; GLUCOSE TOLERANCE; HOMEOBOX 5 GENE; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; LIPID DIET; MALE; METABOLIC PARAMETERS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; DISEASE MODEL; DOWN REGULATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; OBESITY;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHOSPHOPROTEINS; TRANSCRIPTION, GENETIC;

EID: 84963591450     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2016.36     Document Type: Article

References (57)

1. Boonchaya-anant P, Apovian CM. Metabolically healthy obesity-does it exist? Curr Atheroscler Rep 2014; 16: 441.
2. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab 2004; 89: 2583-2589.
3. Bays H. Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction. Curr Opin Endocrinol Diabetes Obes 2014; 21: 345-351.
4. Walker GE, Marzullo P, Ricotti R, Bona G, Prodam F. The pathophysiology of abdominal adipose tissue depots in health and disease. Horm Mol Biol Clin Investig 2014; 19: 57-74.
5. Yazdi FT, Clee SM, Meyre D. Obesity genetics in mouse and human: back and forth, and back again. PeerJ 2015; 3: e856.
6. Apalasamy YD, Mohamed Z. Obesity and genomics: role of technology in unraveling the complex genetic architecture of obesity. Hum Genet 2015; 134: 361-374.
7. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, Morris MJ. Chronic high-fat diet in fathers programs ?-cell dysfunction in female rat offspring. Nature 2010; 467: 963-966.
8. Dunn GA, Bale TL. Maternal high-fat diet effects on third-generation female body size via the paternal lineage. Endocrinology 2011; 152: 2228-2236.
9. Raciti GA, Nigro C, Longo M, Parrillo L, Miele C, Formisano P et al. Personalized medicine and type 2 diabetes: lesson from epigenetics. Epigenomics 2014; 6: 229-238.
10. Mirra P, Raciti GA, Nigro C, Fiory F, D'Esposito V, Formisano P et al. Circulating miRNAs as intercellular messengers, potential biomarkers and therapeutic targets for Type 2 diabetes. Epigenomics 2015; 7: 653-667.
11. Godfrey KM, Sheppard A, Gluckman PD, Lillycrop KA, Burdge GC, McLean C et al. Epigenetic gene promoter methylation at birth is associated with child's later adiposity. Diabetes 2011; 60: 1528-1534.
12. Gluckman PD. Epigenetics and metabolism in 2011: Epigenetics, the life-course and metabolic disease. Nat Rev Endocrinol 2011; 8: 74-76.
13. Gerken T, Girard CA, Tung YC, Webby CJ, Saudek V et al. The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase. Science 2007; 318: 1469-1472.
14. Rodríguez-Gallego E, Guirro M, Riera-Borrull M, Hernández-Aguilera A, Mariné-Casadó R et al. Mapping of the circulating metabolome reveals ?-ketoglutarate as a predictor of morbid obesity-associated non-alcoholic fatty liver disease. Int J Obes (Lond) 2015; 39: 279-287.
15. Toperoff G, Aran D, Kark JD, Rosenberg M, Dubnikov T, Nissan B et al. Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood. Hum Mol Genet 2012; 21: 371-383.
16. Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond. Genes (Basel) 2014; 5: 821-864.
17. Volkmar M, Dedeurwaerder S, Cunha DA, Ndlovu MN, Defrance M, Deplus R et al. DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients. EMBO J 2012; 31: 1405-1426.
18. Miele C, Raciti GA, Cassese A, Romano C, Giacco F, Oriente F et al. PED/PEA-15 regulates glucose-induced insulin secretion by restraining potassium channel expression in pancreatic beta-cells. Diabetes 2007; 56: 622-633.
19. Li Q, Li N, Hu X, Li J, Du Z, Chen L et al. Genome-wide mapping of DNA methylation in chicken. PLoS One 2011; 6: e19428.
20. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25: 1754-1760.
21. Chavez L, Jozefczuk J, Grimm C, Dietrich J, Timmermann B, Lehrach H et al. Computational analysis of genome-wide DNA methylation during the differentiation of human embryonic stem cells along the endodermal lineage. Genome Res 2010; 20: 1441-1450.
22. Smallwood SA, Tomizawa S, Krueger F, Ruf N, Carli N, Segonds-Pichon A et al. Dynamic CpG island methylation landscape in oocytes and preimplantation embryos. Nat Genet 2011; 43: 811-814.
23. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS, Bernstein BE et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol 2008; 9: R137.
24. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18: 1427-1431.
25. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL et al. Chromosomewide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005; 37: 853-862.
26. Fiory F, Parrillo L, Raciti GA, Zatterale F, Nigro C, Mirra P et al. PED/PEA-15 inhibits hydrogen peroxide-induced apoptosis in Ins-1E pancreatic beta-cells via PLD-1. PLoS One 2014; 9: e113655.
27. Kim JH, Dhanasekaran SM, Prensner JR, Cao X, Robinson D, Kalyana-Sundaram S et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 2011; 21: 1028-1041.
28. Bezy O, Elabd C, Cochet O, Petersen RK, Kristiansen K, Dani C et al. Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein beta, implicated in adipocyte differentiation. J Biol Chem 2005; 280: 11432-11438.
29. Kim AY, Park YJ, Pan X, Shin KC, Kwak SH, Bassas AF et al. Obesity-induced DNA hypermethylation of the adiponectin gene mediates insulin resistance. Nat Commun 2015; 6: 7585.
30. Gracia A, Elcoroaristizabal X, Fernández-Quintela A, Miranda J, Bediaga NG et al. Fatty acid synthase methylation levels in adipose tissue: effects of an obesogenic diet and phenol compounds. Genes Nutr 2014; 9: 411.
31. Clark SJ, Harrison J, Frommer M. CpNpG methylation in mammalian cells. Nat Genet 1995; 10: 20-27.
32. Barrès R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K et al. Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab 2009; 10: 189-198.
33. Robertson KD, Keyomarsi K, Gonzales FA, Velicescu M, Jones PA. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. Nucleic Acids Res 2000; 28: 2108-2113.
34. Guibert S, Weber M. Functions of DNA methylation and hydroxymethylation in mammalian development. Curr Top Dev Biol 2013; 104: 47-83.
35. Procino A, Cillo C. The HOX genes network in metabolic diseases. Cell Biol Int 2013; 37: 1145-1148.
36. Smith ZD, Meissner A. DNA methylation: roles in mammalian development. Nat Rev Genet 2013; 14: 204-220.
37. Dolinoy DC, Weidman JR, Jirtle RL. Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 2007; 23: 297-307.
38. Barres R, Kirchner H, Rasmussen M, Yan J, Kantor FR, Krook A et al. Weight loss after gastric bypass surgery in human obesity remodels promoter methylation. Cell Rep 2013; 3: 1020-1027.
39. Benton MC, Johnstone A, Eccles D, Harmon B, Hayes MT, Lea RA et al. An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss. Genome Biol 2015; 16: 8.
40. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature, 2010 8 466: 253-257.
41. Zhang P, Zhao M, Liang G, Yin G, Huang D, Su F et al. Whole-genome DNA methylation in skin lesions from patients with psoriasis vulgaris. J Autoimmun 2013; 41: 17-24.
42. Irizarry RA, Ladd-Acosta C, Wen B, Wu Z, Montano C, Onyango P et al. The human colon cancer methylome shows similar hypo-and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 2009; 41: 178-186.
43. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33: 245-254.
44. Turcot V, Tchernof A, Deshaies Y, Pérusse L, Bélisle A, Marceau S et al. LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin Epigenetics 2012; 4: 10.
45. Hamidi T, Singh AK, Chen T. Genetic alterations of DNA methylation machinery in human diseases. Epigenomics 2015; 7: 247-265.
46. Du Q, Luu PL, Stirzaker C, Clark SJ. Methyl-CpG-binding domain proteins: readers of the epigenome. Epigenomics 2015; 30: 1-23.
47. Kohno D, Lee S, Harper MJ, Kim KW, Sone H, Sasaki T et al. Dnmt3a in Sim1 neurons is necessary for normal energy homeostasis. J Neurosci 2014; 34: 15288-15296.
48. Kamei Y, Suganami T, Ehara T, Kanai S, Hayashi K, Yamamoto Y et al. Increased expression of DNA methyltransferase 3a in obese adipose tissue: studies with transgenic mice. Obesity (Silver Spring) 2010; 18: 314-321.
49. Choi SW, Friso S. Epigenetics: A new bridge between nutrition and health. Adv Nutr 2010; 1: 8-16.
50. Cowherd RM, Lyle RE, Miller CP, Mcgehee RE Jr. Developmental profile of homeobox gene expression during 3T3-L1 adipogenesis. Biochem Biophys Res Commun 1997; 237: 470-475.
51. Charlier C, Segers K, Karim L, Shay T, Gyapay G, Cockett N et al. The callipyge mutation enhances the expression of coregulated imprinted genes in cis without affecting their imprinting status. Nat Genet 2001; 27: 367-369.
52. Dankel SN, Fadnes DJ, Stavrum AK, Stansberg C, Holdhus R, Hoang T et al. Switch from stress response to homeobox transcription factors in adipose tissue after profound fat loss. PLoS One 2010; 5: e11033.
53. Barber BA, Rastegar M. Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann Anat 2010; 192: 261-274.
54. Karastergiou K, Fried SK, Xie H, Lee MJ, Divoux A, Rosencrantz MA et al. Distinct developmental signatures of human abdominal and gluteal subcutaneous adipose tissue depots. J Clin Endocrinol Metab 2013; 98: 362-371.
55. Gesta S, Blüher M, Yamamoto Y, Norris AW, Berndt J, Kralisch S et al. Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci USA 2006; 103: 6676-6681.
56. Dunn J, Qiu H, Kim S, Jjingo D, Hoffman R, Kim CW et al. Flow-dependent epigenetic DNA methylation regulates endothelial gene expression and atherosclerosis. J Clin Invest 2014; 124: 3187-3199.
57. Cao Y. Angiogenesis and vascular functions in modulation of obesity, adipose metabolism, and insulin sensitivity. Cell Metab 2013; 18: 478-489.